MSB
Click for more information
1.83% $1.07 mesoblast limited

Ann: FDA Grants Rare Pediatric Disease Designation for Revascor, page-381

  1. Pledge
    6,704 Posts.
    lightbulb Created with Sketch. 1247
    clock Created with Sketch.
    31/01/24
    15:30
    Post #: 72163161
    Any day now, the FDA will be given Mesoblast approval.


    MSB Price at posting: 26.8¢ Sentiment: Hold Disclosure: Held
    Likes Created with Sketch. 3  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply
 

Featured News

SBM AI helps lead the way for St Barbara to new FY25-27 production targets
right-arrow Created with Sketch.
RDN Raiden opens door to private Mallina in win-win Arrow Gold divestment
right-arrow Created with Sketch.
UNT UNITH's digital humans expand into Amazon; Facebook
right-arrow Created with Sketch.
RCE Recce Pharma picks up Chinese patent for anti-infective drugs
right-arrow Created with Sketch.
CMG Critical Minerals Group boosts JORC by 96% to 713Mt vanadium; others
right-arrow Created with Sketch.
RCE Recce breathes better on positive lung infection drug pilot test results
right-arrow Created with Sketch.

Top Stories

watchlist Created with Sketch. Add MSB (ASX) to my watchlist
(20min delay)
Last
$1.07 		Change
-0.020(1.83%) 		Mkt cap ! $1.210B
Open High Low Value Volume
$1.10 $1.13 $1.05 $5.935M 5.448M

Buyers (Bids)

No. Vol. Price($)
15 32446 $1.07
 

Sellers (Offers)

Price($) Vol. No.
$1.08 104785 11
View Market Depth
Last trade - 14.31pm 10/05/2024 (20 minute delay) ?
Last
$1.08 		  Change
-0.020 ( 1.47 %)
Open High Low Volume
$1.09 $1.13 $1.05 1451066
Last updated 14.50pm 10/05/2024 ?
MSB (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.